RENAISSANCERE HOLDINGS LTDRNR
| Dec 31,
2010 | Dec 31,
2011 | Dec 31,
2012 | Dec 31,
2013 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net income (loss) | 861 | -90 | 749 | 842 | 686 | 542 | 630 | -355 | 269 | 950 | 993 | -103 | -1,160 | 3,620 | 2,961 |
|---|
| Amortization, accretion and depreciation | 60 | 42 | 60 | 52 | 48 | 18 | 29 | 31 | 0 | -59 | 17 | -21 | -27 | -135 | 258 |
|---|
| Equity in undistributed (earnings) losses of other ventures | -24 | -40 | 19 | 15 | 20 | 10 | -6 | -6 | 4 | 1 | -2 | -13 | -11 | 8 | -9 |
|---|
| Net realized and unrealized (gains) losses on investments | 144 | 71 | 164 | 35 | 41 | -69 | 141 | 136 | -175 | 414 | 821 | -206 | -1,635 | 483 | 29 |
|---|
| Premiums receivable | 23 | 150 | 19 | -17 | -34 | 105 | 209 | 317 | 233 | 425 | 294 | 887 | 1,358 | 127 | 10 |
|---|
| Prepaid reinsurance premiums | -14 | -2 | 19 | -11 | 29 | 128 | 211 | 92 | 83 | 12 | 56 | 31 | 167 | -223 | -36 |
|---|
| Reinsurance recoverable | - | 302 | -212 | -91 | -34 | 64 | 145 | 1,307 | 786 | -130 | 138 | 1,343 | 442 | -664 | -863 |
|---|
| Deferred acquisition costs and value of business acquired | -10 | 8 | 9 | 29 | 28 | 89 | 136 | 91 | 50 | -119 | -30 | 216 | 323 | - | -199 |
|---|
| Reserve for claims and claim expenses | - | - | - | - | - | - | - | - | - | 901 | 1,156 | 2,913 | 2,598 | -35 | 817 |
|---|
| Unearned premiums | -46 | 61 | 52 | 78 | 34 | 144 | 342 | 246 | 238 | 51 | 233 | 768 | 1,028 | -227 | -186 |
|---|
| Reinsurance balances payable | -29 | -61 | 34 | 3 | 162 | 65 | 150 | 315 | 913 | 659 | 662 | 373 | 67 | -1,040 | -382 |
|---|
| Other | -4 | 11 | 6 | -160 | 71 | -3 | -85 | -538 | 223 | -251 | -178 | 437 | 259 | 579 | 372 |
|---|
| Net cash provided by (used in) operating activities | 495 | 166 | 717 | 796 | 661 | 415 | 470 | 1,046 | 1,222 | 2,137 | 1,993 | 1,235 | 1,604 | 1,912 | 4,165 |
|---|
| Proceeds from sales and maturities of fixed maturity investments trading | - | 6,089 | 8,193 | 8,251 | 7,683 | 9,482 | 8,103 | 9,491 | 11,586 | 17,314 | 15,187 | 15,544 | 22,086 | 21,797 | 23,515 |
|---|
| Purchases of fixed maturity investments trading | - | 6,272 | 8,536 | 8,466 | 7,639 | 9,683 | 8,283 | 10,094 | 12,490 | 17,919 | 16,837 | 15,680 | 24,923 | 24,771 | 26,297 |
|---|
| Proceeds from sales of equity investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Purchases of equity investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Proceeds from Sale of Short-Term Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31,772 |
|---|
| Purchases of short term investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31,598 |
|---|
| Proceeds from Sale of Other Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,087 |
|---|
| Purchases of other investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,526 |
|---|
| Purchases of investments in other ventures | - | 39 | - | 4 | -1 | 10 | - | - | 21 | 3 | 4 | 24 | 1 | 25 | 57 |
|---|
| Return of investments in other ventures | - | - | - | - | - | - | - | - | 8 | 11 | 9 | 8 | 2 | 6 | 41 |
|---|
| Net purchase of Validus | - | - | - | - | - | 678 | - | - | - | 276 | - | - | - | 2,434 | - |
|---|
| Net cash provided by (used in) investing activities | 109 | 315 | -72 | -316 | 142 | -339 | -165 | -142 | -2,537 | -2,989 | -2,305 | -816 | -3,016 | -3,823 | -3,061 |
|---|
| Dividends paid – RenaissanceRe common shares | 56 | 53 | 53 | 49 | 46 | 54 | 52 | 51 | 53 | 59 | 68 | 68 | 65 | 75 | 81 |
|---|
| Dividends paid – preference shares | 42 | 35 | 35 | 25 | 22 | 22 | 22 | 22 | 30 | 37 | 31 | 33 | 35 | 35 | 35 |
|---|
| RenaissanceRe common share repurchases | 449 | 192 | 463 | 207 | 515 | 260 | 309 | 189 | - | - | 63 | 1,028 | 167 | - | 667 |
|---|
| Proceeds from Issuance of Common Stock | - | - | - | - | - | - | - | - | 250 | - | 1,096 | - | - | 1,352 | - |
|---|
| Proceeds from Issuance of Debt | - | - | - | - | - | 446 | - | 296 | - | 396 | - | - | - | 741 | - |
|---|
| Repayment of Medici Revolving Credit Facility | - | - | - | - | - | - | - | - | - | - | - | - | - | 30 | 150 |
|---|
| Proceeds from Lines of Credit | - | - | - | - | - | - | - | - | - | - | - | 30 | - | 75 | 75 |
|---|
| Proceeds From Repurchase Of Redeemable Noncontrolling Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 537 |
|---|
| Redemptions of third-party redeemable noncontrolling interest shares | - | 62 | -165 | 6 | 112 | 193 | 3 | -260 | - | - | - | - | - | - | 943 |
|---|
| Taxes paid on withholding shares | - | - | - | - | - | - | - | 15 | 8 | 7 | 12 | 12 | 11 | 21 | 24 |
|---|
| Net cash provided by (used in) financing activities | -532 | -542 | -539 | -399 | -695 | -84 | -386 | 29 | 1,066 | 1,120 | 665 | -302 | 725 | 2,589 | -1,288 |
|---|
| Effect of exchange rate changes on foreign currency cash | - | - | - | - | - | - | - | - | - | 2 | 4 | 6 | 22 | 6 | -17 |
|---|
| Net increase (decrease) in cash and cash equivalents | - | - | - | - | - | - | - | - | - | 271 | 358 | 122 | -665 | 683 | -201 |
|---|
| Income Taxes Paid, Net | - | - | - | - | - | - | - | 0 | 0 | 10 | 6 | -4 | 3 | 27 | 100 |
|---|
| Interest paid | - | - | - | - | - | - | - | - | 51 | 53 | 49 | 21 | 46 | 74 | 88 |
|---|
| Non-cash consideration | - | - | - | - | - | - | - | - | - | - | - | - | - | 285 | - |
|---|